Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis
Background: Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) reduce sudden cardiac death and all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF). Current guidelines do not suggest any upper age limit for ICD and CRT but...
Main Authors: | Ahmed AlTurki, Riccardo Proietti, Hasan Alturki, Vidal Essebag, Thao Huynh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Hellenic Journal of Cardiology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1109966617304426 |
Similar Items
-
The current status of cardiac resynchronization therapy and implantable cardioverter defibrillator in China
by: Xiaohan Fan, et al.
Published: (2016-01-01) -
Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials
by: Ahmed AlTurki, et al.
Published: (2019-01-01) -
Loss of cardiac resynchronization therapy in a patient with a biventricular implantable cardioverter-defibrillator
by: Mohammad Alasti, et al.
Published: (2017-12-01) -
Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in the Treatment of Heart Failure with Reduced Ejection Fraction
by: Ilaria Spoletini, et al.
Published: (2017-01-01) -
Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
by: Fang Shawn Foo, et al.
Published: (2020-02-01)